argenx SE
XBRU:ARGX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
argenx SE
XBRU:ARGX
|
NL |
|
DENTSPLY SIRONA Inc
F:DY2
|
US |
|
E
|
Empresas Copec SA
SGO:COPEC
|
CL |
|
V
|
Varun Beverages Ltd
BSE:540180
|
IN |
|
D
|
Daiwa House Industry Co Ltd
SWB:DWH
|
JP |
|
Tharisa PLC
F:7YZ
|
CY |
|
E
|
Enbridge Inc
F:EN3
|
CA |
|
V
|
Vodafone Group PLC
F:VODI
|
UK |
|
I
|
Infraset PCL
SET:INSET
|
TH |
|
National Grid PLC
NYSE:NGG
|
UK |
|
C
|
China Merchants Bank Co Ltd
SWB:M4B
|
CN |
|
CapitaLand Ascott Trust
SGX:HMN
|
SG |
|
Cadiz Inc
NASDAQ:CDZI
|
US |
|
Telefonaktiebolaget LM Ericsson
STO:ERIC B
|
SE |
|
N
|
Nomura Holdings Inc
DUS:NSE
|
JP |
|
Laureate Education Inc
NASDAQ:LAUR
|
US |
|
Citizens Inc
F:YCX
|
US |
|
Tencent Music Entertainment Group
LSE:0A2Z
|
CN |
|
D
|
DENTSPLY SIRONA Inc
DUS:DY2
|
US |
|
Hartadinata Abadi Tbk PT
IDX:HRTA
|
ID |
|
I
|
Imperial Brands PLC
SWB:ITB
|
UK |
|
Hong Kong and China Gas Co Ltd
HKEX:3
|
HK |
|
3D Systems Corp
NYSE:DDD
|
US |
|
L
|
Liaoning Cheng Da Co Ltd
SSE:600739
|
CN |
Bankruptcy Probability
argenx SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
argenx SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
argenx SE
XBRU:ARGX
|
54.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
466.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
63.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
BeOne Medicines AG
SSE:688235
|
227.9B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
argenx SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, argenx SE has total debt of 36m USD. This includes both short-term (0 USD) and long-term (36m USD) debt.
You can find a full breakdown on its Balance Sheet.